Cargando…

Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model

BACKGROUND: Fulminant hepatic failure (FHF) is clinical syndrome with very poor prognosis and high mortality there is urgent need for the development of safe and non-toxic hepatoprotective agents for the adequate management of hepatitis. Hepatoprotective effect of the Lepidium sativum ethanolic extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Raish, Mohammad, Ahmad, Ajaz, Alkharfy, Khalid M., Ahamad, Syed Rizwan, Mohsin, Kazi, Al-Jenoobi, Fahad I., Al-Mohizea, Abdullah M., Ansari, Mushtaq Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135812/
https://www.ncbi.nlm.nih.gov/pubmed/27912738
http://dx.doi.org/10.1186/s12906-016-1483-4
_version_ 1782471613465231360
author Raish, Mohammad
Ahmad, Ajaz
Alkharfy, Khalid M.
Ahamad, Syed Rizwan
Mohsin, Kazi
Al-Jenoobi, Fahad I.
Al-Mohizea, Abdullah M.
Ansari, Mushtaq Ahmad
author_facet Raish, Mohammad
Ahmad, Ajaz
Alkharfy, Khalid M.
Ahamad, Syed Rizwan
Mohsin, Kazi
Al-Jenoobi, Fahad I.
Al-Mohizea, Abdullah M.
Ansari, Mushtaq Ahmad
author_sort Raish, Mohammad
collection PubMed
description BACKGROUND: Fulminant hepatic failure (FHF) is clinical syndrome with very poor prognosis and high mortality there is urgent need for the development of safe and non-toxic hepatoprotective agents for the adequate management of hepatitis. Hepatoprotective effect of the Lepidium sativum ethanolic extract (LSEE) was assessed by D-galactosamine-induced/lipopolysaccharide (400 mg/kg and 30 μg/kg) liver damage model in rats. METHODS: Hepatoprotective activity of LSEE (150 and 300 mg/kg) and silymarin on D-GalN/LPS induced FHF in rat was assessed using several liver function enzyme parameters. Antioxidant properties as antioxidant stress enzymes were assessed in hepatic Liver as well as mRNA expression of cytokines genes such as TNF-α, IL-6, and IL-10 and stress related genes iNOS and HO-1 were determined by RT-PCR. Protein expression of apoptotic genes were evaluated through western blot. MPO and NF-κB DNA-binding activity was analyzed by ELISA. The magnitude of hepatic impairment was investigated through histopathological evaluation. RESULTS: Marked amelioration of hepatic injuries by attenuation of serum and lipid peroxidation has been observed as comparable with silymarin (25 mg/kg p.o). D-GalN/LPS induced significant decrease in oxidative stress markers protein level, and albumin. LSEE significantly down-regulated the D-GalN/LPS induced pro-inflammatory cytokines TNFα and IL-6 mRNA expression in dose dependent fashion about 0.47 and 0.26 fold and up-regulates the IL-10 by 1.9 and 2.8 fold, respectively. While encourages hepatoprotective activity by down-regulating mRNA expression of iNOS and HO-1. MPO activity and NF-κB DNA-binding effect significantly increased and was mitigated by LSEE in a dose-dependent style as paralleled with silymarin. CONCLUSION: Our data suggests that pretreatment of LSEE down regulates the caspase 3 and up-regulates the BCl(2) protein expression. The above findings revealed that Lepidium sativum has significant hepatoprotective activity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1483-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5135812
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51358122016-12-15 Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model Raish, Mohammad Ahmad, Ajaz Alkharfy, Khalid M. Ahamad, Syed Rizwan Mohsin, Kazi Al-Jenoobi, Fahad I. Al-Mohizea, Abdullah M. Ansari, Mushtaq Ahmad BMC Complement Altern Med Research Article BACKGROUND: Fulminant hepatic failure (FHF) is clinical syndrome with very poor prognosis and high mortality there is urgent need for the development of safe and non-toxic hepatoprotective agents for the adequate management of hepatitis. Hepatoprotective effect of the Lepidium sativum ethanolic extract (LSEE) was assessed by D-galactosamine-induced/lipopolysaccharide (400 mg/kg and 30 μg/kg) liver damage model in rats. METHODS: Hepatoprotective activity of LSEE (150 and 300 mg/kg) and silymarin on D-GalN/LPS induced FHF in rat was assessed using several liver function enzyme parameters. Antioxidant properties as antioxidant stress enzymes were assessed in hepatic Liver as well as mRNA expression of cytokines genes such as TNF-α, IL-6, and IL-10 and stress related genes iNOS and HO-1 were determined by RT-PCR. Protein expression of apoptotic genes were evaluated through western blot. MPO and NF-κB DNA-binding activity was analyzed by ELISA. The magnitude of hepatic impairment was investigated through histopathological evaluation. RESULTS: Marked amelioration of hepatic injuries by attenuation of serum and lipid peroxidation has been observed as comparable with silymarin (25 mg/kg p.o). D-GalN/LPS induced significant decrease in oxidative stress markers protein level, and albumin. LSEE significantly down-regulated the D-GalN/LPS induced pro-inflammatory cytokines TNFα and IL-6 mRNA expression in dose dependent fashion about 0.47 and 0.26 fold and up-regulates the IL-10 by 1.9 and 2.8 fold, respectively. While encourages hepatoprotective activity by down-regulating mRNA expression of iNOS and HO-1. MPO activity and NF-κB DNA-binding effect significantly increased and was mitigated by LSEE in a dose-dependent style as paralleled with silymarin. CONCLUSION: Our data suggests that pretreatment of LSEE down regulates the caspase 3 and up-regulates the BCl(2) protein expression. The above findings revealed that Lepidium sativum has significant hepatoprotective activity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1483-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-03 /pmc/articles/PMC5135812/ /pubmed/27912738 http://dx.doi.org/10.1186/s12906-016-1483-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Raish, Mohammad
Ahmad, Ajaz
Alkharfy, Khalid M.
Ahamad, Syed Rizwan
Mohsin, Kazi
Al-Jenoobi, Fahad I.
Al-Mohizea, Abdullah M.
Ansari, Mushtaq Ahmad
Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title_full Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title_fullStr Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title_full_unstemmed Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title_short Hepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
title_sort hepatoprotective activity of lepidium sativum seeds against d-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135812/
https://www.ncbi.nlm.nih.gov/pubmed/27912738
http://dx.doi.org/10.1186/s12906-016-1483-4
work_keys_str_mv AT raishmohammad hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT ahmadajaz hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT alkharfykhalidm hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT ahamadsyedrizwan hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT mohsinkazi hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT aljenoobifahadi hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT almohizeaabdullahm hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel
AT ansarimushtaqahmad hepatoprotectiveactivityoflepidiumsativumseedsagainstdgalactosaminelipopolysaccharideinducedhepatotoxicityinanimalmodel